Literature DB >> 9602075

Specific vanilloid responses in C6 rat glioma cells.

T Bíró1, C Brodie, S Modarres, N E Lewin, P Acs, P M Blumberg.   

Abstract

Capsaicin and its ultrapotent analog resiniferatoxin (RTX) act through specific vanilloid receptors on sensory neurons. Here, we describe specific vanilloid responses in rat C6 glioma cells. Capsaicin and RTX stimulated 45Ca uptake in a similar fashion to that found for cultured rat dorsal root ganglion neurons (DRGs); this response was antagonized by the antagonists capsazepine and ruthenium red. As in DRGs, pretreatment of C6 cells with capsaicin or RTX produced desensitization to subsequent stimulation of 45Ca uptake. The potency for desensitization by RTX in the C6 cells corresponded to that for 45Ca uptake, whereas in DRGs it occurred at significantly lower concentrations corresponding to that for the high affinity [3H]RTX binding site. Consistent with this difference, in C6 cells we were unable to detect [3H]RTX binding. These characteristics suggest the presence of C-type but not R-type vanilloid receptors on C6 cells. After 2 day treatment, capsaicin but not RTX inhibited the proliferation and altered the differentiation of the cells and produced apoptosis. In the long term experiments, capsazepine, instead of antagonizing the effect of capsaicin, acted as an agonist. Moreover, capsazepine displayed these effects with higher potency than that of capsaicin. The different potencies and structure activity relations suggest a distinct mechanism for these long-term vanilloid effects. Our finding that C6 cells can respond directly to capsaicin necessitates a reevaluation of the in vivo pathway of response to vanilloids, and highlights the importance of the neuron-glial network. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9602075     DOI: 10.1016/s0169-328x(98)00033-3

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  8 in total

1.  A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control.

Authors:  Eniko Bodó; Tamás Bíró; Andrea Telek; Gabriella Czifra; Zoltán Griger; Balázs I Tóth; Alessandra Mescalchin; Taisuke Ito; Albrecht Bettermann; László Kovács; Ralf Paus
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

2.  TRPV1 expression in acupuncture points: response to electroacupuncture stimulation.

Authors:  Therese S Abraham; Ming-Liang Chen; Sheng-Xing Ma
Journal:  J Chem Neuroanat       Date:  2011-01-20       Impact factor: 3.052

3.  Vanilloid receptors in hearing: altered cochlear sensitivity by vanilloids and expression of TRPV1 in the organ of corti.

Authors:  Jiefu Zheng; Chunfu Dai; Peter S Steyger; Youngki Kim; Zoltan Vass; Tianying Ren; Alfred L Nuttall
Journal:  J Neurophysiol       Date:  2003-03-26       Impact factor: 2.714

4.  Lipopolysaccharide-induced down-regulation of Ca2+ release-activated Ca2+ currents (I CRAC) but not Ca2+-activated TRPM4-like currents (I CAN) in cultured mouse microglial cells.

Authors:  Andreas Beck; Reinhold Penner; Andrea Fleig
Journal:  J Physiol       Date:  2007-11-08       Impact factor: 5.182

5.  Role of vanilloid receptors in the capsaicin-mediated induction of iNOS in PC12 cells.

Authors:  Shanlou Qiao; Weihua Li; Ryoko Tsubouchi; Keiko Murakami; Masataka Yoshino
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

6.  Signal transduction for inhibition of inducible nitric oxide synthase and cyclooxygenase-2 induction by capsaicin and related analogs in macrophages.

Authors:  Ching-Wen Chen; Sho Tone Lee; Wen Tung Wu; Wen-Mei Fu; Feng-Ming Ho; Wan Wan Lin
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

Review 7.  Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death.

Authors:  Zahra Asadzadeh; Elham Safarzadeh; Sahar Safaei; Ali Baradaran; Ali Mohammadi; Khalil Hajiasgharzadeh; Afshin Derakhshani; Antonella Argentiero; Nicola Silvestris; Behzad Baradaran
Journal:  Cancers (Basel)       Date:  2020-04-23       Impact factor: 6.639

8.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.